When was Entopsis founded?

Entopsis was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is Entopsis located?

Entopsis is headquartered in Miami, United States.

How many employees does Entopsis have?

As of Mar 31, 2026, the latest employee count at Entopsis is 7.

Is Entopsis a funded company?

Entopsis is a funded company, having raised a total of $2.09M across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 2012.

When was the latest funding round of Entopsis?

Entopsis' latest funding was a $***** Series A round on Mar 01, 2021, with participation from 0 investor. Its primary sector is Nanotechnology. In United States, the Nanotechnology sector has seen $61.3M in funding in 2026 to date.

Where does Entopsis rank among its competitors?

Entopsis ranks 2nd amongst 23 active competitors, of which 8 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Tethis, which secured $15.3M in Jan, 2025.

Who are the top competitors of Entopsis?

Entopsis' top competitors include Tethis, GNA Biosolutions and NanoVation-GS. Among them, Tethis secured the most recent funding round in January, 2025.

Entopsis - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of diagnostic device for regular health monitoring. The company makes specialized glass slides called NUTEC that can detect DNA, RNA, proteins, and small molecules through colorimetric change. It also provides software for analysis. using machine learning. The company is primarily focused on areas like oncology, autoimmune and rare diseases.

Website: entopsis.com
Social

Key Metrics

Founded Year

2011

Location

Miami, United States

Stage

Series A

Total Funding

$2.09M in 4 rounds

Latest Funding Round

Series A, Mar 01, 2021, $*****

Investors

Krillion Ventures & 2 more

Ranked

2^nd among 23 active competitors

Employee Count

7 as on Mar 31, 2026

Similar Companies

Tethis & 38 more

View Entopsis' full profile

Entopsis is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Entopsis Llc CIN: 1634457 , United States, Active		$1 - $1M (As on Jan 10, 2017)	-	-

Entopsis has raised a total funding of $2.09M over 4 rounds. Its first funding round was on May 2012. Entopsis has 3 institutional investors.

Here is the list of recent funding rounds of Entopsis:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 01, 2021	7457885	Series A	5204536	5348544	9332801	5723217
Dec 14, 2016	2659288	Seed	8918937	6162954	1802965	6962766
Mar 18, 2015	8437934	Seed	5309430	1086867	Krillion Ventures	G3 Capital Partners

Access funding benchmarks and valuations. Sign up today!

View details of Entopsis's funding rounds and investors

The founders of Entopsis are Ian Cheong and Obdulio Piloto.

Here are the details of Entopsis' key team members:

Ian Cheong: Co-Founder of Entopsis and founder of 1 other company.
Contact Info: 2 email addresses
Obdulio Piloto: Co-Founder & CEO of Entopsis.
Contact Info: 1 email address

View details of Entopsis's Founder profiles and Board Members

Entopsis' employee count trend

Entopsis has 7 employees as of Mar 26. Here is Entopsis's employee count trend over the years:

Uncover Entopsis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Entopsis include Tethis, GNA Biosolutions and NanoVation-GS. Here is the list of Top 10 competitors of Entopsis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tethis 2004, Milan (Italy), Series A	Provider of automated solutions for in liquid biopsy	$15.3M	sanpaolope.com, Indaco Venture Partners & 5 others	43/100
2nd	Entopsis 2011, Miami (United States), Series A	Developer of diagnostic device for regular health monitoring	$2.09M	Breakout Labs, Krillion Ventures & 1 others	42/100
3rd	GNA Biosolutions 2010, Planegg (Germany), Series C	Develops instruments, OEM modules and assays for molecular pathogen detection	$20.2M	OCCIDENT, Bayern Kapital & 11 others	42/100
4th	NanoVation-GS 2014, Haifa (Israel), Series A	Provider of sensor-based respiratory parameters monitoring device	$5.9M	EIC Fund, Europa	41/100
5th	AlphaSIP 2008, Zaragoza (Spain), Funding Raised	Nanotube-based biosensor chip for diagnostic applications	-	EIC Fund, Europa & 2 others	41/100
6th	BioMedomics 2006, Durham (United States), Seed	Point of care diagnostic systems for blood-based disorders	$1.5M	NLVC, NIH & 1 others	36/100
7th	Ellume 2010, Brisbane (Australia), Series A	Developer of a diagnostic device that uses quantum dot nanoparticles to provide real-time patient testing	$5M	Defense.gov, HHS	36/100
8th	SCHOTT MINIFAB 2002, Melbourne (Australia), Unfunded	Developer of microfluidic products	-	-	36/100
9th	NanoCytomics 2011, Evanston (United States), Funding Raised	Revolutionizing cancer risk stratification with innovative, non-invasive diagnostic technology	-	National Science Foundation, HHS	33/100
10th	AgPlus Diagnostics 2011, Sharnbrook (United Kingdom), Seed	Handheld technology platform for disease diagnosis	-	Corporation One, Chase Nominees & 31 others	30/100